Researchers have found that a cancer therapy may prompt a type of immune cell called a macrophage (illustrated above) to attack cancer. Antibodies to the proteins PD-1 and PD-L1 have been shown to fight cancer by unleashing the body’s T cells, a type of immune cell. Now, researchers at the Stanford University School of...